Rfg Advisory, LLC Moderna, Inc. Transaction History

Rfg Advisory, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$126.46 - $235.05 $142,646 - $265,136	-1,128 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$225.82 - $368.51 $121,039 - $197,521	536 Added 90.54%	1,128 $286,000
Q3 2021 Oct 19, 2021	BUY	$221.9 - $484.47 $131,364 - $286,806	592 New	592 $228,000

1,036

245M

12.1M

9.36M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $46.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Rfg Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Rfg Advisory, LLC with notifications on news.